A reversible, orally bioavailable dual inhibitor of IGF-1R and InsR tyrosine kinases (IC₅₀s = 1.8 and 1.7 nM, respectively); inhibits cell proliferation or induces apoptosis in a variety of cancer cells in vitro; inhibits the growth of tumor xenografts in mice.